Viva Biotech Holdings (VBIZF)
USD 0.23
(0.0%)
USD 0.23
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.15 Billion CNY | -9.42% |
| 2022 | 2.37 Billion CNY | 13.1% |
| 2021 | 2.1 Billion CNY | 201.9% |
| 2020 | 696.95 Million CNY | 115.74% |
| 2019 | 323.05 Million CNY | 53.81% |
| 2018 | 210.03 Million CNY | 41.68% |
| 2017 | 148.24 Million CNY | 53.63% |
| 2016 | 96.49 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 67.54 Million USD | 0.0% |
| 2024 Q1 | 67.98 Million USD | -51.49% |
| 2023 FY | 2.15 Billion CNY | -9.42% |
| 2023 Q1 | 83.15 Million USD | -54.45% |
| 2023 Q2 | 164.78 Million USD | 98.17% |
| 2023 Q3 | 69.4 Million USD | -57.88% |
| 2023 Q4 | 140.16 Million USD | 101.97% |
| 2022 FY | 2.37 Billion CNY | 13.1% |
| 2022 Q4 | 182.54 Million USD | 104.39% |
| 2022 Q3 | 89.31 Million USD | -47.64% |
| 2022 Q2 | 170.56 Million USD | 0.0% |
| 2021 Q4 | 167.24 Million USD | 0.0% |
| 2021 FY | 2.1 Billion CNY | 201.9% |
| 2021 Q2 | 158.6 Million USD | 0.0% |
| 2020 Q2 | 28.12 Million USD | 0.0% |
| 2020 Q4 | 73.69 Million USD | 0.0% |
| 2020 FY | 696.95 Million CNY | 115.74% |
| 2019 Q2 | 21.05 Million USD | 0.0% |
| 2019 Q4 | 25.82 Million USD | 0.0% |
| 2019 FY | 323.05 Million CNY | 53.81% |
| 2018 FY | 210.03 Million CNY | 41.68% |
| 2017 FY | 148.24 Million CNY | 53.63% |
| 2016 FY | 96.49 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Nuo Therapeutics, Inc. | 608.52 Thousand USD | -354129.982% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -525439.234% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Evofem Biosciences, Inc. | 18.21 Million USD | -11732.133% |
| GB Sciences, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Skye Bioscience, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Agentix Corp. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | 75.72 Thousand USD | -2846524.584% |
| Biomind Labs Inc. | - USD | -Infinity% |
| ContraFect Corporation | - USD | -Infinity% |
| CSL Limited | 14.69 Billion USD | 85.326% |
| CytoDyn Inc. | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 1.93 Million USD | -111472.36% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Propanc Biopharma, Inc. | - USD | -Infinity% |
| Regen BioPharma, Inc. | 236.56 Thousand USD | -911118.296% |
| Santhera Pharmaceuticals Holding AG | 122.95 Million USD | -1653.161% |
| SQZ Biotechnologies Company | 21.47 Million USD | -9936.214% |
| Therapeutic Solutions International, Inc. | 98.99 Thousand USD | -2177383.484% |
| Eiger BioPharmaceuticals, Inc. | 15.77 Million USD | -13566.252% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -3279442.965% |
| Mesoblast Limited | 5.9 Million USD | -36422.84% |
| Marizyme, Inc. | 645.81 Thousand USD | -333678.975% |
| Genus plc | 668.8 Million USD | -222.305% |
| Pharming Group N.V. | 245.31 Million USD | -778.694% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -2808068.21% |
| IMV Inc. | - USD | -Infinity% |
| AXIM Biotechnologies, Inc. | 39.51 Thousand USD | -5454573.82% |
| MultiCell Technologies, Inc. | 49.32 USD | -4370596007.056% |
| ONE Bio Corp. | 52.29 Million USD | -4021.863% |
| RVL Pharmaceuticals plc | 49.72 Million USD | -4235.347% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 29.59 Million USD | -7183.096% |
| Provectus Biopharmaceuticals, Inc. | 557.71 Thousand USD | -386405.173% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -3079297.143% |
| THC Farmaceuticals, Inc. | - USD | -Infinity% |
| Acro Biomedical Co., Ltd. | 658.5 Thousand USD | -327246.697% |
| Alpha Cognition Inc. | - USD | -Infinity% |
| Enzolytics Inc. | 52.79 Thousand USD | -4082743.397% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.22 Billion USD | -75.777% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | 140.24 Thousand USD | -1536941.685% |
| Genscript Biotech Corporation | 839.52 Million USD | -156.76% |
| Nanobac Pharmaceuticals, Incorporated | 17.62 Thousand USD | -12232906.072% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | - USD | -Infinity% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| Cotinga Pharmaceuticals Inc. | - USD | -Infinity% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| PsyBio Therapeutics Corp. | - USD | -Infinity% |
| Adynxx, Inc. | - USD | -Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 997.72 Thousand USD | -215949.096% |
| EV Biologics, Inc. | 48.9 Thousand USD | -4408034.969% |
| Q BioMed Inc. | 284.35 Thousand USD | -757966.762% |
| Capstone Therapeutics Corp. | 48.35 Million USD | -4357.91% |
| American Oriental Bioengineering, Inc. | 145.09 Million USD | -1385.585% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| BioStem Technologies, Inc. | 16.68 Million USD | -12818.943% |
| Curative Biotechnology, Inc. | - USD | -Infinity% |
| HST Global, Inc. | - USD | -Infinity% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Halberd Corporation | 999.00 USD | -215773473.574% |
| Resverlogix Corp. | - USD | -Infinity% |
| Cell Source, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -349047.046% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Kadimastem Ltd | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| LadRx Corporation | - USD | -Infinity% |
| Regen BioPharma, Inc. | 236.56 Thousand USD | -911118.296% |
| Affymax, Inc. | 1.36 Million USD | -157356.392% |
| Itoco Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| International Stem Cell Corporation | 7.78 Million USD | -27574.644% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| Bioxytran, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Qrons Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 473.73 Thousand USD | -454922.481% |
| SYBLEU INC | 11.69 Thousand USD | -18429944.46% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | - USD | -Infinity% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 13 Thousand USD | -16581269.231% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | - USD | -Infinity% |
| Neutra Corp. | 39.53 Thousand USD | -5452366.232% |
| Windtree Therapeutics, Inc. | - USD | -Infinity% |
| PureTech Health plc | 3.33 Million USD | -64632.072% |
| Coeptis Therapeutics, Inc. | - USD | -Infinity% |
| IXICO plc | 6.66 Million USD | -32241.755% |
| IntelGenx Technologies Corp. | 1.03 Million USD | -207366.603% |
| Gelesis Holdings, Inc. | 25.76 Million USD | -8265.654% |
| CSL Limited | 14.8 Billion USD | 85.435% |
| Cellectis S.A. | 755 Thousand USD | -285407.02% |